Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Geroscience. 2024 Apr;46(2):2051-2062. doi: 10.1007/s11357-023-00965-5. Epub 2023 Oct 10.
Previous studies have found that the association between modifiable risk factors and arterial stiffness varied with age. We aimed to explore the age-specific difference in the relationship between new cardiovascular health (CVH) score and arterial stiffness and further detected the age-specific temporal relationships in a prospective cohort study. During a median 4.3 years follow-up, 3757 participants were recruited in this study. A modified AHA "Life's Essential 8" construct (mLE8 with lacking information on diet habits) was used to evaluate CVH. Branchial-ankle pulse wave velocity (baPWV) was measured to assess arterial stiffness. Data were analyzed with logistic regression models, restricted cubic splines (RCS), and cross-lagged path analysis (age < 60 vs. age ≥ 60). In age-stratified analysis, moderate (OR = 2.21, 95% CI 1.11-4.43) and low (OR = 3.37, 95% CI 1.63-7.00) CVH were related with a higher incidence of elevated baPWV compared to high CVH in middle-aged adults, while this association was not detected in older adults. RCS curve showed a steeper linear association between CVH score and elevated baPWV in middle-aged adults than older individuals. In the cross-lagged path analysis, the decline in CVH score preceded the increment in arterial stiffness in middle-aged adults, but they appeared to alter simultaneously in older adults. Our study detected an age-specific difference in the relationship between mLE8 CVH score and elevated baPWV and showed that low CVH preceded alterations of baPWV in middle-aged adults, suggesting the importance of improvement in CVH during the early stage of the lifespan.
先前的研究发现,可改变的风险因素与动脉僵硬之间的关联随年龄而变化。我们旨在探讨新的心血管健康(CVH)评分与动脉僵硬之间的关系在特定年龄的差异,并在一项前瞻性队列研究中进一步检测特定年龄的时间关系。在中位数为 4.3 年的随访期间,这项研究共招募了 3757 名参与者。采用改良的 AHA“生命的基本 8 项”结构(缺乏饮食习惯信息的 mLE8)来评估 CVH。使用臂踝脉搏波速度(baPWV)来评估动脉僵硬。使用逻辑回归模型、限制性三次样条(RCS)和交叉滞后路径分析(年龄 < 60 岁与年龄 ≥ 60 岁)进行数据分析。在年龄分层分析中,与高 CVH 相比,中老年人中中等(OR = 2.21,95%CI 1.11-4.43)和低(OR = 3.37,95%CI 1.63-7.00)CVH 与升高的 baPWV 发生率较高相关,但在老年人中未发现这种相关性。RCS 曲线显示,中老年人 CVH 评分与升高的 baPWV 之间存在更陡峭的线性关联,而老年人则没有。在交叉滞后路径分析中,CVH 评分的下降先于中老年人动脉僵硬的增加,但在老年人中似乎同时发生变化。我们的研究检测到 mLE8 CVH 评分与升高的 baPWV 之间的关系在特定年龄的差异,并表明低 CVH 先于中老年人 baPWV 的改变,这表明在生命早期改善 CVH 的重要性。